Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
DNA and Cell Biology|February 1, 1997
In vitro and in vivo tumor growth suppression by HIV-1 VprS Mahalingam, B MacDonald, K E Ugen, et al.Nature Medicine|October 23, 1997
HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa BV Ayyavoo, A Mahboubi, S Mahalingam, et al.AIDS (London, England)|December 1, 1992
PASSHIV-1 treatment of patients with HIV-1 infection. A preliminary report of a phase I trial of hyperimmune porcine immunoglobulin to HIV-1K Osther, A Wiik, F Black, et al.Immunologic Research|January 1, 1992
Ocular tissue involvement in HIV infection: immunological and pathological aspectsK E Ugen, D E McCallus, J M Von Feldt, et al.Psychoneuroendocrinology|January 1, 1997
HIV-1 viral protein R (Vpr) as a regulator of the target cellV Ayyavoo, Y Rafaeli, T Nagashunmugam, et al.DNA and Cell Biology|July 1, 1996
Analysis of genetic heterogeneity, antigenicity, and biological characteristics of HIV-1 in a maternal transmitter and nontransmitter patient pairV Ayyavoo, K E Ugen, L S Fernandes, et al.Journal of Neurochemistry|August 1, 1989
Subtype-selective immunoprecipitation of the beta 2-adrenergic receptorC Romano, W V Williams, D J Fischberg, et al.The Journal of Biological Chemistry|April 29, 1998
Construction and binding kinetics of a soluble granulocyte-macrophage colony-stimulating factor receptor alpha-chain-Fc fusion proteinC Monfardini, M Ramamoorthy, H Rosenbaum, et al.Methods in Molecular Medicine|March 5, 2011
Genetic vaccination targeting T-cell receptorsA P Godillot, Q Fang, T Higgins, et al.Immunologic Research|January 1, 1994
Immunotherapeutic strategies targeting rheumatoid synovial T-cell receptors by DNA inoculationW V Williams, Q Fang, J M Von Feldt, et al.Pageof 11